Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-22T15:43:30.186Z Has data issue: false hasContentIssue false

Un caso de acatisia inducida por paroxetina y una revisión de la acatisia inducida por SSRI

Published online by Cambridge University Press:  12 May 2020

F. Bonnet-Brilhault
Affiliation:
Groupe de Recherche Psychopathologie et Schizophrénies (JE 2014), CH du Rouvray, Service Hospitalo-Universitaire, 4 rué Paul Eluard, 76301Sotteville-lés-Rouen, Francia
F. Thibaut
Affiliation:
Groupe de Recherche Psychopathologie et Schizophrénies (JE 2014), CH du Rouvray, Service Hospitalo-Universitaire, 4 rué Paul Eluard, 76301Sotteville-lés-Rouen, Francia
A. Leprieur
Affiliation:
Groupe de Recherche Psychopathologie et Schizophrénies (JE 2014), CH du Rouvray, Service Hospitalo-Universitaire, 4 rué Paul Eluard, 76301Sotteville-lés-Rouen, Francia
M. Petit
Affiliation:
Groupe de Recherche Psychopathologie et Schizophrénies (JE 2014), CH du Rouvray, Service Hospitalo-Universitaire, 4 rué Paul Eluard, 76301Sotteville-lés-Rouen, Francia
Get access

Extract

Desde la publicación en 1989 del artículo de Lipinski et al [14] que informaba de la presencia de acatisia en cinco pacientes tratados con fluoxetina, ha habido varios informes de acatisia asociada con otros inhibidores selectivos de la recaptación de serotonina (SSRI), como la sertralina y, últimamente, la paroxetina. Además de la incomodidad que sienten los pacientes, las complicaciones secundarias más notables son el incumplimiento terapéutico y la ideación y la conducta suicidas. Queremos informar sobre un nuevo caso de acatisia durante el tratamiento de paroxetina y revisar los rasgos clínicos, así como la patofisiología de este trastorno.

Type
Informe clínico
Copyright
Copyright © European Psychiatric Association 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Bonnet-Brilhault F, Thibaut F, Leprieur A, Petit M. A case of paroxetine-induced akathisia and a review of SSRI-induced akathisia. Eur Psychiatry 1998; 13: 109-111.

References

Bibliografía

Adler, LAAngrist, BM. Paroxetine and akathisia. Biol Psychiatry 1995; 37: 336-7.CrossRefGoogle ScholarPubMed
Altshuler, LLPierre, JMWirsching, WCAmes, D, Sertraline and akathisia. J Clin Psychopharmacol 1994; 14: 278-9.CrossRefGoogle ScholarPubMed
Baldassano, CFTruman, CTNierenberg, A, Nassir Ghaemi SN, Sachs GS. Akathisia: a review and case report following paroxetine treatment. Comp Psychiatry 1996; 37: 122-4.CrossRefGoogle ScholarPubMed
Barnes, TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154: 672-6.CrossRefGoogle ScholarPubMed
Bing, R. Über einige bemerkenswerte belgleiterscheinungen der extrapyramidalen rigidität (akathisie, mikrograhite, kinesia paradoxica). Schweiz Med Wochenschr 1923; 53: 162-77.Google Scholar
Blaisdell, GD. Akathisia: a comprehensive review and treatment summary. Pharmacopsychiatry 1994; 27: 139-46.CrossRefGoogle ScholarPubMed
Braude, WMBarnes, TREGore, SM, Clinical characteristics of akathisia: a systematic investigation of acute psychiatric inpatient admissions. Br J Psychiatry 1983; 143: 139-50.CrossRefGoogle ScholarPubMed
Delay, JPDeniker, AGreen, HMordret, P, Le syndrome excitomoteur provoqué par les médicaments neuroleptiques. Presse Med 1957; 65: 1771-4.Google Scholar
Dray, ADavis, AOakly, RR, The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological biochemical and behavioural observations. Brain Res 1978; 151: 431-42.CrossRefGoogle ScholarPubMed
Hamilton, MSOpler, LAAkathisia suicidality and fluoxetine, J Clin Psychiatry 1992; 53: 401-6.Google ScholarPubMed
Haskovec, L. Nouvelles remarques sur l’akathisie. Nouv Iconograph, Salpêtriêre 1903; 16: 287-96.Google Scholar
Klee, BKronig, MH. Case report of probable sertraline induced akathisia. Am J Psychiatry 1993; 150: 986-7.Google ScholarPubMed
Laporta, LD. Sertraline-induced akathisia. J Clin Psychopharmacol 1993; 13: 219-20.CrossRefGoogle ScholarPubMed
Lipinski, JFMallya, GZimmerman, PPope, HG, Fluoxetine-induced akathisia: clinical and theoretical implications. J Clin Psychiatry 1989; 50: 339-42.Google ScholarPubMed
Marsden, CDJenner, P. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med 1980; 10: 5572.CrossRefGoogle ScholarPubMed
Olivera, AA. A case of paroxetine-induced akatnisia. Biol Psychiatry 1996; 39: 909-10.CrossRefGoogle Scholar
Opler, LA. Sertraline and akathisia. Am J Psychiatry 1994; 151: 620-1.Google ScholarPubMed
Shihabuddin, LRapport, D. Sertraline and extrapyramidal side effects. Am J Psychiatry 1994; 151: 288.Google ScholarPubMed
Simpson, GIAngus, JWS. A rating scale for experimental side effects. Acta Psychiatr Scand 1970; 212: 11-9.CrossRefGoogle Scholar
Sternbach, H. The serotonin syndrome. Am J Psychiatry 1991; 148: 705-13.Google ScholarPubMed
Tassin, JPStinus, LSimon, HBlanc, GThierry, AMLeMoal, H, Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic enervation in the rat. Brain Res 1978; 141: 267-81.CrossRefGoogle Scholar
Teicher, MHGlod, ECole, JV, Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990; 147: 207-10.Google ScholarPubMed
Putten T, Van, SR, Marder. Behavioral toxicity of antipsychotic drugs. J Clin Psychiatry 1987; 48: 13-9.Google ScholarPubMed
Wilbur, RKulik, AV. Noradrenergic effects in tardive dyskinesia, akathisia and pseudoparkinsonism in the limbic system and basal ganglia. Prog Neuropsychopharmacol Biol Psychiatry 1988; 12: 849-64.CrossRefGoogle ScholarPubMed
Wirshing, WC, Van Putten T, Rosenberg J, Marder S, Ames D, Hicks-Gray T. Fluoxetine, akathisia, and suicidality: is there a causal connection? Arch Gen Psychiatry 1992; 49: 580-1.Google Scholar